JPMorgan Funds - Thematics - Genetic Therapies C (acc) - CHF (hedged)

WKN A2PXUM | ISIN LU2098775385 |  Fonds
Factsheet
04.11.26
94,61 CHF  +1,37 % (+1,28)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU2314628996 JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR +34,45 % +20,27 % 1,56
2 LU1991432631 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK +36,56 % +23,41 % 1,44
3 LU2053354044 JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - GBP (hedged) +32,43 % +20,91 % 1,42
4 LU1120766032 Candriam Equities L Biotechnology, I - Capitalisation +34,03 % +22,36 % 1,40
5 LU2053353822 JPMorgan Funds - Thematics - Genetic Therapies A (acc) - GBP (hedged) +31,68 % +20,91 % 1,38
34 LU2098775385 JPMorgan Funds - Thematics - Genetic Therapies C (acc) - CHF (hedged) +27,39 % +20,95 % 1,18
116 CH0113817123 Bellevue Biotech DT CHF +15,56 % +20,51 % 0,63
117 LU1176840327 Protea Fund - Sectoral Biotech Opportunities Fund PF USD +16,14 % +22,02 % 0,61
118 LU3110815787 CPR Invest - Biodiversity - IF1 EURH1 - Acc +8,97 % +11,69 % 0,53
119 LU3110815944 CPR Invest - Biodiversity - IF2 EURH1 - Acc +8,75 % +11,69 % 0,52
120 LU1711916616 Protea Fund - Sectoral Biotech Opportunities Fund IF H CHF +11,52 % +21,92 % 0,40